Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Effects of Tegaserod vs. Placebo on Whole Gut Transit Time in Patients With Chronic Constipation and Dyspepsia

This study has been withdrawn prior to enrollment.
Sponsor:
Collaborator:
Mayo Clinic
Information provided by (Responsible Party):
Novartis
ClinicalTrials.gov Identifier:
NCT00277550
First received: January 13, 2006
Last updated: March 2, 2016
Last verified: March 2016
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given